Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

888
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
888

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A Single-Center Prospective Study on Adverse Drug Reactions Associated With Polypharmacy in Elderly Outpatients.

Cureus·2026
Same author

A Quality Improvement Initiative of Standard 1 of the British Orthopaedic Association Standards for Trauma (BOAST) for Management of Supracondylar Fractures in Children.

Cureus·2025
Same author

Patterns of Head CT Utilization in Emergency Department Patients With Minor Head Injury: A Systematic Review.

Cureus·2025
Same author

Menopausal Women With Diabetes and Comorbid Anxiety: Integrated Management Involving Cognitive Behavioral Therapy, Diabetes Education, and Pharmacotherapy.

Cureus·2025
Same author

Prospective Evaluation of Low-Dose Theophylline as an Add-On Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD).

Cureus·2025
Same author

Impact of Oral Mesalamine on Clinical Remission and Mucosal Response in Mild to Moderate Ulcerative Colitis: A Prospective Observational Study.

Cureus·2025

関連する実験動画

Updated: Sep 9, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.6K

妊娠糖尿病 と 女性 の 心血管 リスク: 血栓 症,血静 症,凝固 と 線維 解 析 に 関する 新しい 洞察 の 総合 的 レビュー

Shahid Shehzad1, Nosheena A Shabbir2, Marium Mumtaz3

  • 1Endocrinology and Diabetes, Bacha Khan Medical College, Mardan, PAK.

Cureus
|September 5, 2025
PubMed
まとめ
この要約は機械生成です。

妊娠中の糖尿病 (GDM) は,フィブリノゲンとD- ダイマー濃度の上昇によって示される前血栓状態に関連しています. これは,GDM妊娠における統合された心血管と静脈のモニタリングの必要性を強調しています.

キーワード:
心血管リスク凝固する繊維分解妊娠糖尿病トロンボシス

さらに関連する動画

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

914
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K

関連する実験動画

Last Updated: Sep 9, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.6K
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

914
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.1K

科学分野:

  • 産婦人科
  • 心血管医学
  • 血液学

背景:

  • 妊娠中の糖尿病 (GDM) は,心臓血管および血栓性リスクの上昇と関連していることがますます認識されています.
  • 血管機能不全の初期指標を特定するために,GDMにおける静脈と代謝の変化を理解することは極めて重要です.
  • この研究は,GDMと診断された妊婦のこれらのプロフィールを評価することに焦点を当てています.

研究 の 目的:

  • GDMの女性におけるフィブリノゲン,D- ダイマー,プラズミノゲン活性化剤阻害剤-1 (PAI-1),および抗血栓を評価する.
  • GDM妊娠における血管機能障害と血栓性リスクの早期マーカーを探求する.
  • 併発症や治療方法がこれらのマーカーに与える影響を調査する.

主な方法:

  • GDMと診断された250人の妊婦を対象とした遡及的横断研究です.
  • 代用マーカーであるフィブリノゲン,D-ダイマー,PAI-1,抗血栓を用いて心血管リスクの評価
  • 血圧,BMI,喫煙状態,併発性疾患を含む臨床データの分析;治療効果 (インスリン,メトホルミン,ダイエット) の調査.

主要な成果:

  • GDMの女性は,前血栓状態を示す抗血栓活性低下とともに,フィブリノゲン,D- ダイマー,PAI-1のレベルが上昇した.
  • 肥満,高血圧,喫煙などの併発性疾患は,血栓形成のリスクを悪化させることが観察されました.
  • 異なるGDM治療方法において,血静性マーカーの有意な変化は認められなかった.

結論:

  • 妊娠中の糖尿病は,血管のストレスの生化学的マーカーと高血栓性に関連しています.
  • この結果は,GDM妊娠における統合的血静性および心血管監視の重要性を強調しています.
  • 原因関係を確認し,リスクの階層化を改善するために,ノルモグリセミック妊娠とのさらなる比較研究が推奨されます.